Evaluation of the Feasibility and Clinical Relevance of Liquid Biopsy in Patients With Suspicious Metastatic Lung Cancer
Not Applicable
Completed
- Conditions
- Metastatic Lung Cancer
- Interventions
- Diagnostic Test: InvisionFirst® molecular panel
- First Posted Date
- 2018-10-26
- Last Posted Date
- 2023-08-31
- Lead Sponsor
- Centre Leon Berard
- Target Recruit Count
- 319
- Registration Number
- NCT03721120
- Locations
- 🇫🇷
Centre Maurice Tubiana, Caen, France
🇫🇷Infirmerie Protestante, Caluire et Cuire, France
🇫🇷Hopital Louis Pradel, Bron, France
Trametinib + HDM201 in CRC Patients With RAS/RAF Mutant and TP53 Wild-type Advanced/Metastatic Colorectal Cancer Mutant and TP53 Wild-type
Phase 1
Completed
- Conditions
- Colorectal CancerAdvanced CancerMetastatic Cancer
- Interventions
- First Posted Date
- 2018-10-22
- Last Posted Date
- 2023-09-13
- Lead Sponsor
- Centre Leon Berard
- Target Recruit Count
- 12
- Registration Number
- NCT03714958
- Locations
- 🇫🇷
Centre Leon Berard, Lyon, France
BIOREN (Predictive BIOmarkers in Metastatic RENal Cancer)
- Conditions
- Renal Cancer Metastatic
- First Posted Date
- 2018-08-14
- Last Posted Date
- 2022-03-15
- Lead Sponsor
- Centre Leon Berard
- Target Recruit Count
- 30
- Registration Number
- NCT03628859
- Locations
- 🇫🇷
Centre Leon Berard, Lyon, France
Evaluation of Clinical Impact of Interruption VS Maintenance of AI in Patients with Locally Advanced/ Metastatic Low Grade Endometrial Stromal Sarcoma (LGESS)
Phase 2
Recruiting
- Conditions
- Low Grade Endometrial Stromal Sarcoma
- Interventions
- Drug: Aromatase Inhibitors
- First Posted Date
- 2018-08-10
- Last Posted Date
- 2025-03-21
- Lead Sponsor
- Centre Leon Berard
- Target Recruit Count
- 40
- Registration Number
- NCT03624244
- Locations
- 🇫🇷
CHU Tours, Tours, France
🇫🇷CHU Besançon, Besançon, France
🇫🇷Insitut Bergonié, Bordeaux, France
Impact of Pegfilgrastim on Trastuzumab Anti-tumor Effect and ADCC in Operable HER2+ Breast Cancer Breast Cancer
Phase 2
Recruiting
- Conditions
- HER2-positive Breast CancerOperable Breast Cancer
- Interventions
- First Posted Date
- 2018-06-27
- Last Posted Date
- 2024-08-26
- Lead Sponsor
- Centre Leon Berard
- Target Recruit Count
- 90
- Registration Number
- NCT03571633
- Locations
- 🇫🇷
Centre Hospitalier Universitaire de Saint Etienne, Saint-Étienne, France
🇫🇷Centre Leon Berard, Lyon, France
🇫🇷CHRU Besançon, Besançon, France
Efficacy of Exercise Using Connected Activity Trackers and Therapeutic Education in Localized Breast Cancer
Not Applicable
Completed
- Conditions
- Breast Cancer
- Interventions
- Device: Connected deviceBehavioral: Therapeutic education
- First Posted Date
- 2018-05-18
- Last Posted Date
- 2023-03-22
- Lead Sponsor
- Centre Leon Berard
- Target Recruit Count
- 436
- Registration Number
- NCT03529383
- Locations
- 🇫🇷
CHRU Besançon, Besançon, France
🇫🇷Institut Sainte-Catherine, Avignon, France
🇫🇷Centre Léon Bérard, Lyon, France
Clinical and Biological Activity of an Anti-PD-L1 (Atezolizumab) in Operable Localised Soft Tissue Sarcomas Patients to be Treated With Radiotherapy
Phase 2
Recruiting
- Conditions
- Sarcoma,Soft Tissue
- Interventions
- Combination Product: Pre-operative radiotherapy followed by 2 cycles of atezolizumab then surgeryCombination Product: 2 cycles of atezolizumab followed by surgery then post-operative radiotherapyCombination Product: Pre-operative radiotherapy followed by surgery then 2 cycles of atezolizumab.
- First Posted Date
- 2018-03-22
- Last Posted Date
- 2023-01-27
- Lead Sponsor
- Centre Leon Berard
- Target Recruit Count
- 69
- Registration Number
- NCT03474094
- Locations
- 🇫🇷
Institut Gustave Roussy, Villejuif, France
🇫🇷Institut Bergonie, Bordeaux, France
🇫🇷Institut Claudius Regaud, Toulouse, France
The βIG-H3 Protein: a New Marker in PANCreatic Adenocarcinoma (BIGHPANC)
Active, not recruiting
- Conditions
- Pancreas Adenocarcinoma
- Interventions
- Procedure: Biological Samples
- First Posted Date
- 2018-03-21
- Last Posted Date
- 2022-12-06
- Lead Sponsor
- Centre Leon Berard
- Target Recruit Count
- 80
- Registration Number
- NCT03472716
- Locations
- 🇫🇷
Centre Léon Bérard, Lyon, France
Efficacy of Cryotherapy Combined or Not With Analgesics in Uncontrolled Painful Musculoskeletal Metastasis
Not Applicable
Terminated
- Conditions
- Musculoskeletal Pain
- Interventions
- Drug: Medical AnalgesicsOther: Cryotherapy + Medical analgesics
- First Posted Date
- 2018-02-22
- Last Posted Date
- 2021-10-19
- Lead Sponsor
- Centre Leon Berard
- Target Recruit Count
- 18
- Registration Number
- NCT03441139
- Locations
- 🇫🇷
Centre Léon Bérard, Lyon, France
🇫🇷Institut Bergonié, Bordeaux, France
🇫🇷Institut de Cancérologie de Montpellier-Val d'Aurelle, Montpellier, France
Satisfaction and Quality of Life Comparison Between Patients Using Cicaplast Baume B5 Versus Dexeryl for the Management of Cutaneous Toxicities Induced by Epidermal Growth Factor Receptor Inhibitors (iEGFR)
Not Applicable
Completed
- Conditions
- Non Small Cell Lung CancerColorectal CancerEpidermal Growth Factor Receptor InhibitorHead and Neck Squamous Cell Carcinoma
- Interventions
- Other: Cicaplast Balm B5Other: Dexeryl
- First Posted Date
- 2018-02-05
- Last Posted Date
- 2021-07-09
- Lead Sponsor
- Centre Leon Berard
- Target Recruit Count
- 102
- Registration Number
- NCT03421912
- Locations
- 🇫🇷
Centre Léon Bérard, Lyon, Rhône, France
© Copyright 2025. All Rights Reserved by MedPath